Gene · 602
Papers2,356
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,356
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene Expression Insights into Cytarabine Resistance in Acute Myeloid Leukemia: The Role of Cytokines. | Cancer Genomics Proteomics | 2025 | 40883022 | PubTator, text mining | PubMed |
| Pinpointing novel targets for osteoarthritis: A comprehensive cross-omics integration analysis. | Medicine (Baltimore) | 2025 | 40859561 | PubTator, text mining | PubMed |
| Immunosenescence and cancer: molecular hallmarks, tumor microenvironment remodeling, and age-specific immunotherapy challenges. | J Hematol Oncol | 2025 | 40846970 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Reveals LEF1 as a Prognostic Biomarker for Poor Outcomes in Oxaliplatin-Resistant Colorectal Cancer. | Hum Mutat | 2025 | 40810004 | PubTator, text mining | PubMed |
| Distinct glial functions are associated with Alzheimer's disease based on cell-type- and pathway-specific polygenic risk score analysis. | J Alzheimers Dis | 2025 | 40776626 | PubTator, text mining | PubMed |
| Serotype-specific host proteome remodeling in human foreskin fibroblasts during lytic HSV-1 and HSV-2 infection. | Virol J | 2025 | 40660299 | PubTator, text mining | PubMed |
| Therapeutic Insights Into a Case-Control Approach to B-cell Lymphoma 3 (BCL3)-Encoded Protein by Exploring Immune Modulation and Clinical Strategies in Oral Carcinomas. | Cureus | 2025 | 40486320 | PubTator, text mining | PubMed |
| Integrative Transcriptomic Profiling Identifies TNF and IL1B as Candidate Key Early-Response Genes in Macrophages Infected with Smooth Brucella Using a Comprehensive Bioinformatic Approach. | Biology (Basel) | 2025 | 40427768 | PubTator, text mining | PubMed |
| Regulation and Function of the Atypical IκBs-Bcl-3, IκBNS, and IκBζ-in Lymphocytes and Autoimmunity. | Eur J Immunol | 2025 | 40359334 | PubTator, text mining | PubMed |
| Liver-specific Bcl3 Knockout Alleviates Acetaminophen-induced Liver Injury by Activating Nrf2 Pathway in Male Mice. | Cell Mol Gastroenterol Hepatol | 2025 | 40015625 | PubTator, text mining | PubMed |
| Immune checkpoint protein PD-L1 promotes transcription of angiogenic and oncogenic proteins IL-8, Bcl3, and STAT1 in ovarian cancer cells. | J Biol Chem | 2025 | 39988077 | PubTator, text mining | PubMed |
| An optimised Bcl-3 inhibitor for melanoma treatment. | Br J Pharmacol | 2025 | 39943627 | PubTator, text mining | PubMed |
| Determination of IL-17, BCL-3 and IκBζ expression levels in the gingival crevicular fluid of psoriasis patients. | Arch Dermatol Res | 2025 | 39786665 | PubTator, text mining | PubMed |
| Bismuth-Metal and Carbon Quantum Dot Co-Doped NiAl-LDH Heterojunctions for Promoting the Photothermal Catalytic Reduction of CO2. | Small | 2025 | 39690807 | PubTator, text mining | PubMed |
| Identification of BCL3 as a biomarker for chondrocyte programmed cell death in osteoarthritis. | Int J Exp Pathol | 2025 | 39676743 | PubTator, text mining | PubMed |
| Corrigendum to "BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombination" [DNA Repair 115 (2022) 103331]. | DNA Repair (Amst) | 2025 | 39657282 | PubTator, text mining | PubMed |
| The molecular determinants of phenotypic plasticity in homeostasis and neoplasia. | Cancer Heterog Plast | 2024 | 40994652 | PubTator, text mining | PubMed |
| MicroRNAs: where brilliance, perseverance, and ambition converged. | J Clin Invest | 2024 | 39656547 | PubTator, text mining | PubMed |
| BCL3, GBP1, IFI16, and CCR1 as potential brain-derived biomarkers for parietal grey matter lesions in multiple sclerosis. | Sci Rep | 2024 | 39557900 | PubTator, text mining | PubMed |
| METTL3 facilitates kidney injury through promoting IRF4-mediated plasma cell infiltration via an m6A-dependent manner in systemic lupus erythematosus. | BMC Med | 2024 | 39501302 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/602/papers?page=3